These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 657595

  • 21. [Clinical and pathological characteristics of children with dense deposit disease].
    Liu JC, Yang JY, Xiao HJ, Huang JP, Yao Y, Li X, Wang SX.
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):593-7. PubMed ID: 19951492
    [Abstract] [Full Text] [Related]

  • 22. [An approach to research on nephritic factor and membranoproliferative glomerulonephritis].
    Ohi H.
    Nihon Jinzo Gakkai Shi; 2012 Aug; 54(7):1006-15. PubMed ID: 23234212
    [Abstract] [Full Text] [Related]

  • 23. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V, Weiss L, Brun P, Kazatchkine MD.
    Nephrol Dial Transplant; 1994 Aug; 9(7):811-4. PubMed ID: 7970124
    [Abstract] [Full Text] [Related]

  • 24. Streptococcal infection as possible trigger for dense deposit disease (C3 glomerulopathy).
    Prasto J, Kaplan BS, Russo P, Chan E, Smith RJ, Meyers KE.
    Eur J Pediatr; 2014 Jun; 173(6):767-72. PubMed ID: 24384791
    [Abstract] [Full Text] [Related]

  • 25. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
    Iitaka K, Moriya S, Nakamura S, Tomonaga K, Sakai T.
    Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
    [Abstract] [Full Text] [Related]

  • 26. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
    Strife CF, Jackson EC, McAdams AJ.
    Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
    [Abstract] [Full Text] [Related]

  • 27. [Clinicopathological survey of persistent hypocomplementemic glomerulonephritis in children; correlation of DPGN and MPGN type I].
    Hattori S, Hiramatsu M, Ushijima T, Karashima S, Furuse A, Matsuda I, Takebayashi S.
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):773-81. PubMed ID: 1479716
    [Abstract] [Full Text] [Related]

  • 28. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977 Jul; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

  • 29. Histopathology of MPGN and C3 glomerulopathies.
    Cook HT, Pickering MC.
    Nat Rev Nephrol; 2015 Jan; 11(1):14-22. PubMed ID: 25447133
    [Abstract] [Full Text] [Related]

  • 30. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 31. Focal and diffuse membranoproliferative glomerulonephritis in children.
    Yoshikawa N, Yoshiara S, Yoshiya K, Matsuo T, Matsuyama S, Okada S.
    Am J Nephrol; 1988 Apr; 8(2):102-7. PubMed ID: 3293441
    [Abstract] [Full Text] [Related]

  • 32. [Renal biopsy in children with isolated microhematuria].
    Batinić D, Sćukanec-Spoljar M, Milosević D, Nizić L, Vrljicak K, Matković M.
    Acta Med Croatica; 2002 Apr; 56(4-5):163-6. PubMed ID: 12768895
    [Abstract] [Full Text] [Related]

  • 33. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB, Tarantino A, Bazzi C, Colasanti G, Guerra L, Durante A.
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [Abstract] [Full Text] [Related]

  • 34. Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
    Ferrario F, Rastaldi MP.
    J Nephrol; 2004 Jul; 17(4):483-6. PubMed ID: 15372408
    [Abstract] [Full Text] [Related]

  • 35. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation.
    Jackson EC, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD.
    Am J Kidney Dis; 1987 Feb; 9(2):115-20. PubMed ID: 3826060
    [Abstract] [Full Text] [Related]

  • 36. Membranoproliferative glomerulonephritis type 1: comparison of natural history in children and adults.
    Magil AB, Price JD, Bower G, Rance CP, Huber J, Chase WH.
    Clin Nephrol; 1979 May; 11(5):239-44. PubMed ID: 378493
    [Abstract] [Full Text] [Related]

  • 37. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.
    Sethi S, Fervenza FC.
    Semin Nephrol; 2011 Jul; 31(4):341-8. PubMed ID: 21839367
    [Abstract] [Full Text] [Related]

  • 38. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
    [Abstract] [Full Text] [Related]

  • 39. Dense intramembranous deposit disease: new pathologic features.
    Sibley RK, Kim Y.
    Kidney Int; 1984 Apr; 25(4):660-70. PubMed ID: 6482170
    [Abstract] [Full Text] [Related]

  • 40. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF, McEnery PT, McAdams AJ, West CD.
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.